AZTherapies, INC — Form D/A

AZTherapies, INC of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2018-10-16. The offering totals $25.5M, of which $16.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Thierry PorteDirectorST. HELIER, Y9
Keith GreenfieldDirectorWaltham, MA
Gillian SandlerDirectorNew York, NY
John R PorterDirectorAtlanta, GA
Peter ContiDirectorBoston, MA
George BehrakisDirectorBoston, MA
Brian BartlettExecutive OfficerBoston, MA
Noah GottdienerDirectorNew York, NY
Karen ReevesExecutive OfficerBoston, MA
David TaftDirectorBoston, MA
David ElmalehDirectorBoston, MA
David ElmalehExecutive OfficerBoston, MA
Robert S WarrenExecutive OfficerBoston, MA
Keith S GreenfieldDirectorBoston, MA
Keith S GreenfieldExecutive OfficerBoston, MA
David S TaftDirectorBoston, MA
Ronald S TompkinsDirectorBoston, MA
Brian T BartlettExecutive OfficerBoston, MA
George T BehrakisDirectorBoston, MA
Gillian T SandlerDirectorBoston, MA
Karen T ReevesExecutive OfficerBoston, MA
Jay T MohrExecutive OfficerBoston, MA
Peter S ContiDirectorBoston, MA
John S PorterDirectorBoston, MA
Karen S ReevesExecutive OfficerBoston, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2020-09-15D$35.0M$14.8M
2019-07-12D$37.5M$19.0M
2019-05-31D$7.5M$5.6M
2018-07-03D$15.0M$7.7M
2017-12-18D$6.0M$1.6M
2017-11-15D/A$7.6M$6.5M
2017-06-30D$5.9M$3.7M
2017-02-06D/A$20.0M$16.1M
2015-12-07D$20.0M$13.8M
2015-01-06D$13.0M$6.1M

More